Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Santini P, Pola R. Letter by Santini and Pola Regarding Article, "Rivaroxaban for 18 Months versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)". Circulation 2025;152:e89.
PMID: 40920837


Privacy Policy